Below are white paper reports that I have published through the Marwood Group. These publications explore various health policy areas that attract the interest of institutional investors.
How Urgent Care Centers Can Position Themselves For Continued Growth After COVID-19 (January 2024)
Demand for urgent care services has increased over the last few years due to increased awareness of urgent care centers following the COVID-19 pandemic, as well as shifting consumer preferences and payor steerage toward urgent care over alternative care settings. Although increased demand has led to some saturated markets, expansion of service offerings, such as primary care add-ons and joint ventures with hospitals, positions the urgent care market for continued growth..
Opportunities In Fertility Services –
Regulatory Considerations For Surrogacy Agencies (August 2023)
Surrogacy has become an increasingly popular fertility service that enjoys positive regulatory environments across much of the country. The emergence and growth of experienced surrogacy agencies with strong domain expertise and interpersonal capabilities not only reduces barriers for intended parents, surrogates and clinicians, but also provides opportunities for investors to enter and expand into this space. In this white paper, I address the growing demand and consumer-sensitive market for surrogacy services in the U.S., the supportive political and legal landscape American surrogacy agencies enjoy compared to providers in international markets, and the increasing numbers of large companies and employers adopting surrogacy as part of their family-building benefit.
Opportunities In Fertility Services –
The Importance Of State-Level Analysis (May 2023)
Demand for fertility services has grown over the last few years, along with increasing insurance coverage mandates and rising interest from large employer groups. In the absence of federal policy, states have taken on a more active role in requiring commercial coverage and reimbursement of infertility treatment. Although the post-Roe political landscape in the United States could deter individuals from seeking out reproductive care, state abortion bans do not have any direct impact on assisted reproductive technology and pose limited risk to fertility treatment service providers. In this white paper, I address the considerable tailwinds in state regulatory and commercial payor policy that create an attractive environment in the fertility space.
Opportunities For Growth And Consolidation
In The Cosmetic Surgery & Medspa Market (May 2023)
While cosmetic surgery & medspa procedure platforms have rarely achieved scale to date, they are a growing area of investor focus, supported by an aging population and positive consumer trends in aesthetics catalyzed through the COVID-19 pandemic. In this white paper, I explore corporate practice of medicine regulations and recent state policy trends on limitations for opioid prescriptions.
Scott Silberberg 